Management
Sequoia’s team possesses depth of experience in managing successful scientific and business operations.
The versatile R&D team is anchored by a multidisciplinary core of scientists consisting of chemists, biochemists, structural biologists, molecular biologists, and virologists familiar with the novel technologies and ideas on which Sequoia was founded.
Brian Wynne , MD.
Brian Wynne, MD is Vice President of Clinical Development and Medical Affairs. While at GlaxoSmithKline, he led the clinical development of several pediatric and adult antibiotics, as well as the early phases of a novel topical antibiotic. Dr. Wynne's work at GSK ranged from early stage and discovery teams to leading the design, conduction, analysis and reporting of several pivotal studies, which led to successful registration and licensing of both antibiotic and antimalarial drugs.
Dr. Wynne was the medical monitor for several phase 1 studies, for both antibiotic and antimalarial drugs.
Dr. Wynne volunteers his time as an attending physician in the HIV clinic at Hahnemann University, and teaches Infectious Disease Fellows.
Dr. Wynne is a graduate of The Medical College of Ohio, and completed residency in Internal Medicine at the Northeast Ohio University College of Medicine / The Akron City Hospital. After residency, he practiced clinical and academic medicine for 5 years. Following this, he completed a fellowship in Infectious Diseases at the Medical College of Pennsylvania.